This pattern seems to NASDAQ:ATXI have reached a bottom, showing signs of reversal as it has broken upward. The pattern formed over 8 hours and 45 minutes, which is a rough guide for how long it might take to reach the target price of 0.85 - 0.89.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015...
All,
ATXI I think goes 100% in mid term. Overally they are ironing out and FDA approval with a few other pipelines. At this price I cant imagine why not just add this to your portfolio as a hold. May scale into this one every month or so.
Hi, @assafff123
Ok so, personally, I do love Biotech stocks... I don't know why but I love them.
The bad news is that there is no support since 2.22 and it broke below that I cannot tell you how low it will go - there's just no support.
There are TWO gaps that need to be filled to the UP side (look for the red arrows)... and even if just the first gap fills...
ATXI had the last bullish news on the 20 of november 20, since then, we are only recieving bearish news.
We dropped to an significant low and it looks like there is a wide room to climb up again.
The only question is when to enter ?
Well, it is hard to define due the reason we are on the current all time low, the price could fall further. Anyway I think there is...
i like this more than DNN, i sold out of DNN for this slight loss wanted to have fun buying at resistance
i have a limit sell on this thing at $12. set it and forget it
big gap to fill on her i like the break out as well
very little selling volume
i think it'll move like HD did
Contextual immersion trading strategy idea.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in...
NASDAQ:ATXI TRADED ON HIGH VOLUME AND A INITIAL 30% PRICE SPIKE ON MONDAY BUT SOLD OFF AS THE MARKET CONDITIONS DETERIORATED THROUGHOUT THE DAY. KEEP ON STRONG WATCH AS A MUCH GREATER MOVE IS EXPECTED ON SUCH STRONG RESULTS.
COMPANY COMMENTS
“The strong safety and efficacy results from this second Phase 3 trial are consistent with those from the first Phase 3...
